Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Combination of cyclopamine and tamoxifen promotes survival and migration of MCF-7 breast cancer cells – interaction of Hedgehog-Gli and Estrogen receptor signaling pathways (CROSBI ID 213783)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Sabol, Maja ; Trnski, Diana ; Užarević, Zvonimir ; Ozretić, Petar ; Musani, Vesna ; Rafaj, Maja ; Cindrić, Mario ; Levanat, Sonja Combination of cyclopamine and tamoxifen promotes survival and migration of MCF-7 breast cancer cells – interaction of Hedgehog-Gli and Estrogen receptor signaling pathways // PLoS One, 9 (2014), 12; e114510-1-e114510-23. doi: 10.1371/journal.pone.0114510

Podaci o odgovornosti

Sabol, Maja ; Trnski, Diana ; Užarević, Zvonimir ; Ozretić, Petar ; Musani, Vesna ; Rafaj, Maja ; Cindrić, Mario ; Levanat, Sonja

engleski

Combination of cyclopamine and tamoxifen promotes survival and migration of MCF-7 breast cancer cells – interaction of Hedgehog-Gli and Estrogen receptor signaling pathways

Hedgehog-Gli (Hh-Gli) signaling pathway is one of the new molecular targets found upregulated in breast tumors. Estrogen receptor alpha (ERα) signaling has a key role in the development of hormone-dependent breast cancer. We aimed to investigate the effects of inhibiting both pathways simultaneously on breast cancer cell survival and the potential interactions between these two signaling pathways. ER-positive MCF-7 cells show decreased viability after treatment with cyclopamine, a Hh-Gli pathway inhibitor, as well as after tamoxifen (an ERα inhibitor) treatment. Simultaneous treatment with cyclopamine and tamoxifen on the other hand, causes short-term survival of cells, and increased migration. We found upregulated Hh-Gli signaling under these conditions and protein profiling revealed increased expression of proteins involved in cell proliferation and migration. Therefore, even though Hh-Gli signaling seems to be a good potential target for breast cancer therapy, caution must be advised, especially when combining therapies. In addition, we also show a potential direct interaction between the Shh protein and ERα in MCF-7 cells. Our data suggest that the Shh protein is able to activate ERα independently of the canonical Hh-Gli signaling pathway. Therefore, this may present an additional boost for ER-positive cells that express Shh, even in the absence of estrogen

PTCH1; Gli1; sonic hedgehog; estrogen receptor; breast cancer

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

9 (12)

2014.

e114510-1-e114510-23

objavljeno

1932-6203

10.1371/journal.pone.0114510

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost